Proof of Usefulness Report

Health Tech Alliance

Analysis completed on 1/26/2026

+46
Proof of Usefulness Score
You're In Business

The Health Tech Alliance is a verifiable, influential UK coalition with significant real-world utility in the healthcare sector. However, the submission itself contains critical inconsistencies and low-quality data (e.g., claiming 'everyone' as the audience, stating 'most people have used my product' for a B2B alliance, and listing 'marketcap' instead of revenue). While the entity described is high-value, the proof provided in this submission is flawed and unreliable, resulting in a heavily penalized score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+21.25
Audience Reach Impact+4.0
Technical Innovation+3.0
Evidence Of Traction+6.25
Market Timing Relevance+8.0
Functional Completeness+0.25
Subtotal+42.75
Usefulness Multiplierx1.08
Final Score+46

Project Details

Description
The Health Tech Alliance is an informal coalition of health tech companies working to drive up the adoption of medical technologies, devices and diagnostics that are prove to benefit patient outcomes and deliver cost savings to the NHS. Chaired by Dame Barbara Hakin, the former Deputy Chief Executive of NHS England, the Alliance’s members range from start-ups to multinational companies. We work constructively with key bodies such as NICE, NHS England, Office for Life Sciences, NHS Improvement, NIHR and the Academic Health Science Networks to find tangible solutions to key healthcare problems. Why join the Alliance? - Regular face-to-face meetings with key stakeholders within NHS England, NICE, NHS Improvement, Department of Health, Office for Life Sciences and others. - Direct involvement with major NHS programmes such as the ‘Getting It Right First Time’ (GIRFT) programme. - Timely updates on breaking policy and political developments. - Exclusive access to hear about major announcements – e.g. Members heard from NICE first about the MedTech Early Technical Assessment (META) Tool before it was publicly launched. - Involvement in member-led workstreams focused on identifying viable solutions to the common challenges that the industry faces. - Opportunities to collaborate and share best practice with leading market access experts and other industry members.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline